✦ LIBER ✦
607 POSTER Impressive anti-tumor activity of combined erbB1 and erbB2 blockade: a phase I and pharmacokinetics (PK) study of OSl-774 (Erlotinib; E) and Trastuzumab (T) in combination with weekly Paclitaxel (P) in patients (pts) with advanced solid tumors
✍ Scribed by M. Beeram; J.S. De Bono; E.K. Rowinsky; P. O'Rourke; A. Ricart; L.A. Hammond; A. Patnaik; M. Mita; A. Mita; A.W. Tolcher
- Book ID
- 118624235
- Publisher
- Elsevier Science
- Year
- 2006
- Tongue
- English
- Weight
- 53 KB
- Volume
- 4
- Category
- Article
- ISSN
- 1359-6349
No coin nor oath required. For personal study only.